About Biomed Realty Trust (NYSE:BMR)
BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryOffice REITs
SectorN/A
SymbolNYSE:BMR
CUSIP09063H10
Phone+1-858-4859840
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins18.98%
Return on Equity3.73%
Return on Assets2.07%
Miscellaneous
EmployeesN/A
Outstanding Shares203,530,000
Biomed Realty Trust (NYSE:BMR) Frequently Asked Questions
What is Biomed Realty Trust's stock symbol?
Biomed Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BMR."
How were Biomed Realty Trust's earnings last quarter?
Biomed Realty Trust Inc (NYSE:BMR) released its quarterly earnings data on Tuesday, April, 28th. The real estate investment trust reported $0.41 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.37 by $0.04. The real estate investment trust had revenue of $178.01 million for the quarter, compared to the consensus estimate of $167.08 million. Biomed Realty Trust had a return on equity of 3.73% and a net margin of 18.98%. The company's quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.38 earnings per share. View Biomed Realty Trust's Earnings History.
Who are some of Biomed Realty Trust's key competitors?
Some companies that are related to Biomed Realty Trust include Berkshire Hathaway (BRK.B), Berkshire Hathaway (BRK.A), Alibaba Group (BABA), JPMorgan Chase (JPM), Johnson & Johnson (JNJ), ExxonMobil (XOM), Bank of America (BAC), Royal Dutch Shell (RDS.B), Royal Dutch Shell (RDS.A), Walmart (WMT), Visa (V), Wells Fargo (WFC), Chevron (CVX), UnitedHealth Group (UNH), Taiwan Semiconductor Mfg. (TSM), Pfizer (PFE), AT&T (T) and The Home Depot (HD).
Who are Biomed Realty Trust's key executives?
Biomed Realty Trust's management team includes the folowing people:
- Greg N. Lubushkin, Chief Financial Officer (Age 62)
- James R. Berens, President of Wexford Science & Technology (Age 61)
- Jonathan Paul Klassen, Executive Vice President, General Counsel, Secretary (Age 39)
- John P. Bonanno, Executive Vice President, Leasing & Development (Age 49)
- Karen A. Sztraicher, Executive Vice President - Asset Management (Age 51)
Has Biomed Realty Trust been receiving favorable news coverage?
News headlines about BMR stock have trended somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Biomed Realty Trust earned a media sentiment score of 0.09 on Accern's scale. They also gave headlines about the real estate investment trust an impact score of 44.46 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Biomed Realty Trust?
Shares of BMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Biomed Realty Trust's stock price today?
One share of BMR stock can currently be purchased for approximately $23.81.
How can I contact Biomed Realty Trust?
Biomed Realty Trust's mailing address is 17190 Bernardo Center Dr, SAN DIEGO, CA 92128-7030, United States. The real estate investment trust can be reached via phone at +1-858-4859840.
MarketBeat Community Rating for Biomed Realty Trust (BMR)
MarketBeat's community ratings are surveys of what our community members think about Biomed Realty Trust and other stocks. Vote "Outperform" if you believe BMR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMR will underperform the S&P 500 over the long term. You may vote once every thirty days.
Biomed Realty Trust (NYSE:BMR) Dividend Information
Biomed Realty Trust pays an annual dividend of $1.04 per share, with a dividend yield of 4.37%. BMR's most recent quarterly dividend payment was Thursday, October 15.
| Most Recent Dividend: | 10/15/2015 |
| Annual Dividend: | $1.04 |
| Dividend Yield: | 4.37% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | N/A |
Biomed Realty Trust (NYSE:BMR) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 9/16/2015 | quarterly | $0.26 | 5.35% | 9/28/2015 | 9/30/2015 | 10/15/2015 |
| 6/16/2015 | quarterly | $0.26 | 5.22% | 6/26/2015 | 6/30/2015 | 7/15/2015 |
| 3/17/2015 | quarterly | $0.26 | 4.73% | 3/27/2015 | 3/31/2015 | 4/15/2015 |
| 12/12/2014 | special | $0.30 | 4.88% | 12/18/2014 | 12/22/2014 | 12/29/2014 |
| 12/12/2014 | quarterly | $0.26 | 4.88% | 12/29/2014 | 12/31/2014 | 1/15/2015 |
| 9/16/2014 | quarterly | $0.25 | 4.73% | 9/26/2014 | 9/30/2014 | 10/15/2014 |
| 6/16/2014 | quarterly | $0.25 | 4.54% | 6/26/2014 | 6/30/2014 | 7/15/2014 |
| 3/17/2014 | quarterly | $0.25 | 4.87% | 3/27/2014 | 3/31/2014 | 4/15/2014 |
| 12/16/2013 | quarterly | $0.25 | 5.46% | 12/27/2013 | 12/31/2013 | 1/15/2014 |
| 9/16/2013 | quarterly | $0.2350 | 4.83% | 9/26/2013 | 9/30/2013 | 10/15/2013 |
| 6/17/2013 | quarterly | $0.2350 | 4.61% | 6/26/2013 | 6/28/2013 | 7/15/2013 |
| 3/18/2013 | quarterly | $0.2350 | 4.3% | 3/26/2013 | 3/28/2013 | 4/15/2013 |
| 12/14/2012 | quarterly | $0.2350 | 4.95% | 12/27/2012 | 12/31/2012 | 1/15/2013 |
(Data available from 1/1/2013 forward)
Biomed Realty Trust (NYSE:BMR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
